Bath & Body Works (NYSE:BBWI) Director Francis Hondal Acquires 3,343 Shares of Stock

Bath & Body Works, Inc. (NYSE:BBWI) Director Francis Hondal purchased 3,343 shares of the company’s stock in a transaction dated Friday, November 21st. The stock was purchased at an average cost of $14.99 per share, for a total transaction of $50,111.57. Following the transaction, the director owned 21,554 shares of the company’s stock, valued at approximately $323,094.46. This trade represents a 18.36% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $15.58 on Tuesday. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $41.87. The firm has a market capitalization of $3.21 billion, a PE ratio of 4.62, a PEG ratio of 0.86 and a beta of 1.53. The business’s 50-day simple moving average is $24.37 and its 200-day simple moving average is $28.00.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the company posted $0.49 earnings per share. The firm’s revenue was down 1.0% compared to the same quarter last year. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. Research analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Investors of record on Friday, November 21st will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 5.1%. The ex-dividend date is Friday, November 21st. Bath & Body Works’s payout ratio is currently 24.62%.

Wall Street Analysts Forecast Growth

BBWI has been the subject of a number of research reports. Citigroup reduced their price objective on Bath & Body Works from $35.00 to $21.00 and set a “buy” rating for the company in a research report on Friday. JPMorgan Chase & Co. reduced their target price on Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating for the company in a research report on Thursday, November 20th. Robert W. Baird reissued a “neutral” rating and issued a $19.00 price target (down previously from $33.00) on shares of Bath & Body Works in a report on Thursday. Wall Street Zen cut shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, October 8th. Seven analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $26.84.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Danske Bank A S bought a new position in Bath & Body Works in the 3rd quarter valued at $39,000. Advisory Services Network LLC acquired a new stake in shares of Bath & Body Works in the third quarter valued at $48,000. Dark Forest Capital Management LP raised its holdings in shares of Bath & Body Works by 91.3% in the third quarter. Dark Forest Capital Management LP now owns 101,662 shares of the company’s stock valued at $2,619,000 after buying an additional 48,525 shares during the last quarter. XTX Topco Ltd acquired a new position in Bath & Body Works during the 3rd quarter worth about $1,256,000. Finally, United Capital Financial Advisors LLC bought a new stake in Bath & Body Works during the 3rd quarter worth about $263,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.